The use of intravenous immune globulin to reduce panel reactive antibodies in children with end stage renal disease.
Moore
Cammie
C
Department of Medicine, University of North Carolina, Chapel Hill, USA.
D000293:Adolescent; D000906:Antibodies / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000276:immunology / Q000628:therapy*; D016030:Kidney Transplantation / Q000276:immunology*; D017582:Renal Replacement Therapy
D000906:Antibodies; D006680:HLA Antigens; D016756:Immunoglobulins, Intravenous